U.S. Microarray Market (2025 - 2033) Size, Share & Trends Analysis Report By Product & Services (Instruments, Consumables, Software & Services), By Type (DNA Microarray, Protein Microarray), By Application, By End Use, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Product and Services
                        1.2.2. Type
                        1.2.3. Application
                        1.2.4. End Use
                        1.2.5. Regional scope
                        1.2.6. Estimates and forecasts timeline.
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Approach 1: Commodity flow approach
                        1.7.3. Volume price analysis (Model 2)
                        1.7.4. Approach 2: Volume price analysis
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Product and Services Outlook
                        2.2.2. Application Outlook
                        2.2.3. End Use Outlook
                        2.2.4. Regional outlook
                    2.3. Competitive Insights
Chapter 3. U.S. Microarray Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook.
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                            3.2.1.1. Rising demand for personalized medicine and genomic research
                            3.2.1.2. Technological advancements in microarray platforms
                            3.2.1.3. Expanding applications in diagnostics and infectious disease testing
                        3.2.2. Market restraint analysis
                            3.2.2.1. High cost of microarray instruments and consumables
                    3.3. U.S. Microarray Market Analysis Tools
                        3.3.1. Industry Analysis Porter’s
                        3.3.2. PESTEL Analysis
Chapter 4. U.S. Microarray Market: Product and Services Estimates & Trend Analysis
                    4.1. Product and Services Market Share, 2024 & 2033
                    4.2. Segment Dashboard
                    4.3. U.S. Microarray Market by Product and Services Outlook
                    4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
                        4.4.1. Consumables
                            4.4.1.1. Consumables market estimates and forecasts 2021 to 2033 (USD Million)
                        4.4.2. Instruments
                            4.4.2.1. Instruments market estimates and forecasts 2021 to 2033 (USD Million)
                        4.4.3. Software and Services
                            4.4.3.1. Software and services market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. U.S. Microarray Market: Type Estimates & Trend Analysis
                    5.1. Type Market Share, 2024 & 2033
                    5.2. Segment Dashboard
                    5.3. U.S. Microarray Market by Type Outlook
                    5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
                        5.4.1. DNA Microarray
                            5.4.1.1. DNA Microarray market estimates and forecasts 2021 to 2033 (USD Million)
                        5.4.2. Protein Microarray
                            5.4.2.1. Protein microarray market estimates and forecasts 2021 to 2033 (USD Million)
                        5.4.3. Others
                            5.4.3.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. U.S. Microarray Market: Application Estimates & Trend Analysis
                    6.1. Application Market Share, 2024 & 2033
                    6.2. Segment Dashboard
                    6.3. U.S. Microarray Market by Application Outlook
                    6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
                        6.4.1. Research applications
                            6.4.1.1. Research application market estimates and forecasts 2021 to 2033 (USD Million)
                        6.4.2. Drug discovery
                            6.4.2.1. Drug discovery market estimates and forecasts 2021 to 2033 (USD Million)
                        6.4.3. Disease diagnostics
                            6.4.3.1. Disease diagnostics market estimates and forecasts 2021 to 2033 (USD Million)
                        6.4.4. Others
                            6.4.4.1. Others application market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. U.S. Microarray Market: End use Estimates & Trend Analysis
                    7.1. End Use Market Share, 2024 & 2033
                    7.2. Segment Dashboard
                    7.3. U.S. Microarray Market by End use Outlook
                    7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
                        7.4.1. Research and Academic Institutes
                            7.4.1.1. Research and Academic Institutes market estimates and forecasts 2021 to 2033 (USD Million)
                        7.4.2. Pharmaceutical and Biotechnology Companies
                            7.4.2.1. Pharmaceutical and Biotechnology Companies market estimates and forecasts 2021 to 2033 (USD Million)
                        7.4.3. Diagnostic Laboratories
                            7.4.3.1. Diagnostic Laboratories market estimates and forecasts 2021 to 2033 (USD Million)
                        7.4.4. Others
                            7.4.4.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 8. Competitive Landscape
                    8.1. Recent Developments & Impact Analysis by Key Market Participants
                    8.2. Company Categorization
                    8.3. Company Heat Map Analysis
                    8.4. Company Profiles
                        8.4.1. Thermo Fisher Scientific Inc (Applied Biosystems)
                            8.4.1.1. Company overview
                            8.4.1.2. Financial performance
                            8.4.1.3. Services benchmarking
                            8.4.1.4. Strategic initiatives
                        8.4.2. Agilent Technologies, Inc
                            8.4.2.1. Company overview
                            8.4.2.2. Financial performance
                            8.4.2.3. Services benchmarking
                            8.4.2.4. Strategic initiatives
                        8.4.3. Illumina, Inc
                            8.4.3.1. Company overview
                            8.4.3.2. Financial performance
                            8.4.3.3. Services benchmarking
                            8.4.3.4. Strategic initiatives
                        8.4.4. PerkinElmer
                            8.4.4.1. Company overview
                            8.4.4.2. Financial performance
                            8.4.4.3. Services benchmarking
                            8.4.4.4. Strategic initiatives
                        8.4.5. Merck KGaA
                            8.4.5.1. Company overview
                            8.4.5.2. Financial performance
                            8.4.5.3. Services benchmarking
                            8.4.5.4. Strategic initiatives
                        8.4.6. Schott (Applied Microarrays)
                            8.4.6.1. Company overview
                            8.4.6.2. Financial performance
                            8.4.6.3. Services benchmarking
                            8.4.6.4. Strategic initiatives
                        8.4.7. Danaher Corporation
                            8.4.7.1. Company overview
                            8.4.7.2. Financial performance
                            8.4.7.3. Services benchmarking
                            8.4.7.4. Strategic initiatives
                        8.4.8. Arrayit Corporation
                            8.4.8.1. Company overview
                            8.4.8.2. Financial performance
                            8.4.8.3. Services benchmarking
                            8.4.8.4. Strategic initiatives
                        8.4.9. Bio-Rad Laboratories, Inc
                            8.4.9.1. Company overview
                            8.4.9.2. Financial performance
                            8.4.9.3. Services benchmarking
                            8.4.9.4. Strategic initiatives
                        8.4.10. Microarrays Inc
                            8.4.10.1. Company overview
                            8.4.10.2. Financial performance
                            8.4.10.3. Services benchmarking
                            8.4.10.4. Strategic initiatives

List of Tables

Table 1 List of key distributors and channel partners
Table 2 List of key emerging companies’/technology disruptors/innovators
Table 3 U.S. microarray market, by product and services, 2021 - 2033 (USD Million)
Table 4 U.S. microarray market, by type, 2021 - 2033 (USD Million)
Table 5 U.S. microarray market, by application, 2021 - 2033 (USD Million)
Table 6 U.S. microarray market, by end use, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research
Fig. 4 Value-chain-based sizing & forecasting
Fig. 5 QFD modelling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Commodity flow analysis
Fig. 8 Market outlook
Fig. 9 Segment snapshot-1
Fig. 10 Segment snapshot-2
Fig. 11 Competitive landscape snapshot
Fig. 12 Market trends & outlook
Fig. 13 Porter’s five force analysis
Fig. 14 PESTEL analysis
Fig. 15 U.S. microarray market: Product and Services outlook key takeaways
Fig. 16 U.S. microarray market: Product and Services movement analysis
Fig. 17 U.S. Microarray: Product and Services movement analysis
Fig. 18 U.S. Microarray: Product and Services outlook and key takeaways
Fig. 19 Consumables market estimates and forecast, 2021 - 2033
Fig. 20 Instruments market estimates and forecast, 2021 - 2033
Fig. 21 Software and services market estimates and forecast, 2021 - 2033
Fig. 22 U.S. Microarray: Type movement analysis
Fig. 23 U.S. Microarray: Type outlook and key takeaways
Fig. 24 DNA microarray market estimates and forecasts, 2021 - 2033
Fig. 25 Protein microarray market estimates and forecasts, 2021 - 2033
Fig. 26 Others market estimates and forecasts, 2021 - 2033
Fig. 27 U.S. Microarray: Application movement analysis
Fig. 28 U.S. Microarray: application outlook and key takeaways
Fig. 29 Research applications market estimates and forecasts, 2021 - 2033
Fig. 30 Drug discovery market estimates and forecasts, 2021 - 2033
Fig. 31 Disease diagnostics market estimates and forecasts, 2021 - 2033
Fig. 32 Others applications market estimates and forecasts, 2021 - 2033
Fig. 33 U.S. Microarray: End Use movement analysis
Fig. 34 U.S. Microarray: End Use outlook and key takeaways
Fig. 35 Research and academic institutes market estimates and forecasts, 2021 - 2033
Fig. 36 Pharmaceutical and biotechnology companies market estimates and forecasts, 2021 - 2033
Fig. 37 Diagnostic laboratories market estimates and forecasts, 2021 - 2033
Fig. 38 Others market estimates and forecasts, 2021 - 2033